Imatinib Active Not Recruiting Phase 2 Trials for Graft Versus Host Disease (GVHD) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02891395Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host